Navigation Links
DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments
Date:8/29/2014

rall strategy to meet the requirements to list our common stock on a national securities exchange in the most expeditious manner possible.  We believe this is an important component of executing on our overall mission to increase shareholder value."

The following tables represent selected financial information as at June 30, 2014 and December 31, 2013. The Company's financial information has been prepared in accordance with U.S. GAAP and this selected information should be read in conjunction with DelMar's financial statements and Management's Discussion and Analysis, as filed.

Selected Balance Sheet Data:June 30,2014$December 31,2013$Cash and cash equivalents4,759,711

4,136,803Working capital4,704,044

4,069,261Total Assets5,003,910

4,318,748Derivative liability3,329,367

4,402,306Total shareholders' equity (deficiency)880,479

(817,978)Selected Statement of Operations Data (net of share-based payments):Six Months endedJune 30,2014$June 30,2013$Research & development net of share-based compensation848,335

907,223General & administrative net of share-based compensation1,007,781

1,363,406The largest component of research and development expenses are attributable to clinical development costs as the Company continued with its Phase I/II clinical trial with VAL-083 in GBM. The clinical development costs were slightly lower in the current period compared to the prior period due to several factors including timing of p
'/>"/>

SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
8. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
9. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
10. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
11. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014   Vestagen Technical ... the patient experience at hospitals. The myComfort™ line of ... active barrier fabric that is fluid repellant, breathable and ... inhibit the growth of bacteria on the fabric i ... clothing plays in the chain of transmission. We want ...
(Date:9/16/2014)... , Sept. 16, 2014 Northwest Biotherapeutics ... company developing DCVax® personalized immune therapies for solid tumor ... product to receive formal designation as a "Promising Innovative ... Scheme" (EAMS) launched in the UK in April 2014. ... process for early access approval under the EAMS.  ...
(Date:9/16/2014)... 2014 CorMedix Inc. ("CorMedix") (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... amendment and restatement of its outstanding Series C-2, ... warrants, as well as the warrants issued in ... to remove anti-dilution, price reset and certain change ...
Breaking Medicine Technology:New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3
... 2011 Cellular Dynamics International (CDI) today announced the ... Blood demonstrating for the first time a methodology ... of banked blood samples through the creation of induced ... "Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent ...
... Advanced Sterilization Products (ASP) announced today the ... GLOSAIR™ Healthcare Environmental Decontamination – that provides effective, ... operating suites to reduce the risk of patient ... scientific consensus that the patient environment is a ...
Cached Medicine Technology:Cellular Dynamics International Unlocks the Potential of Banked Blood Samples 2ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 2ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 3ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 4ASP Launches GLOSAIR™ Healthcare Environmental Decontamination at the 2011 APIC Conference to Protect Against the Risk of Deadly Infections in Healthcare Facilities 5
(Date:9/17/2014)... In honor of National Health IT Week Sept. ... professionals for gaining a competitive edge in the healthcare ... demand for qualified health IT professionals are at an ... differentiating factor when filling a position. The skill most ... clinical workflow and terminology experience. American Sentinel offers ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 On October ... wellness to the lineup at Techmanity, a celebration of ... next generation of tech events,” Techmanity will host the ... excited to join the ranks of Cisco, PayPal, Samsung, ... ever Silicon Valley Technology Conference. , Voom was created ...
(Date:9/17/2014)... Presence Technology, a multinational provider of ... 10.0, which incorporates significant enhancements to meet the ... The Contact Center Agents and Supervisors will have ... a better feel for the performance of their ... who requires additional coaching or mentoring to raise ...
(Date:9/16/2014)... (PRWEB) September 17, 2014 Top10BestSEOHosting.com ... announced the most recommended companies for the webmasters ... at affordable rates. , The senior spokesman ... http://www.arvixe.com/6883.html ), Bluehost and HostMonster are the excellent ... managed to provide a wide range of advanced ...
(Date:9/16/2014)... report a poorer experience of care during pregnancy and ... care, suggests a new study published today (17 September) ... Gynaecology ( BJOG ). , Differences in health ... many areas and have provided the focus for national ... , The Oxford University study, funded by the National ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2Health News:Top10BestSEOHosting.com: Arvixe Is One Of The Best SEO Hosting Suppliers 2Health News:A greater focus on socially disadvantaged women is needed to improve maternity care in England 2
... the most common form of brain cancer might fare better ... alone . ,Based on findings of the study it ... known as glioblastoma receive surgery to remove as much of ... The current study compared 573 patients with glioblastomas who were ...
... to a study in Journal of Dental Research, caries in ... ,A primary tooth can have caries for a wide ... socio-economic status, years of exposure to water fluoridation, disturbance to ... all these differences, can caries in primary teeth have long-term ...
... variant that may increase the risk of late-onset Alzheimer’s ... understanding of the disease and new prevention and treatment ... specific changes in the gene in a protein called ... ,In previous studies, researchers studied Alzheimer’s patients and ...
... recent issue of Journal of American Medical Association, researchers have ... in delaying the vaccination schedules of the children resulting in ... ,According to the latest study, most of the ... years of age in children often gets delayed due to ...
... people it was found that men who drank six cups ... 12 to 18 years, while women who drank that amount ... their study revealed an unequivocal evidence for an inverse and ... other risk factors. However researchers say the reasons for ...
... paper presented at American College of Cardiology, laughter can ... presenter of the paper Michael Miller, MD, director of ... medicine at the University of Maryland in Baltimore, had ... healthy and 150 people suffering cardiac problems. ,The ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: